Filing Details
- Accession Number:
- 0001127602-15-026566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-03 16:20:45
- Reporting Period:
- 2015-09-01
- Filing Date:
- 2015-09-03
- Accepted Time:
- 2015-09-03 16:20:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1542768 | E Maria Cantor | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Svp, Corporate Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-09-01 | 2,696 | $9.11 | 104,917 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 17,2014.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.95 to $9.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote.